BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

255 related articles for article (PubMed ID: 14505273)

  • 1. Myotonic dystrophy type 2: human founder haplotype and evolutionary conservation of the repeat tract.
    Liquori CL; Ikeda Y; Weatherspoon M; Ricker K; Schoser BG; Dalton JC; Day JW; Ranum LP
    Am J Hum Genet; 2003 Oct; 73(4):849-62. PubMed ID: 14505273
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Confirmation of the type 2 myotonic dystrophy (CCTG)n expansion mutation in patients with proximal myotonic myopathy/proximal myotonic dystrophy of different European origins: a single shared haplotype indicates an ancestral founder effect.
    Bachinski LL; Udd B; Meola G; Sansone V; Bassez G; Eymard B; Thornton CA; Moxley RT; Harper PS; Rogers MT; Jurkat-Rott K; Lehmann-Horn F; Wieser T; Gamez J; Navarro C; Bottani A; Kohler A; Shriver MD; Sallinen R; Wessman M; Zhang S; Wright FA; Krahe R
    Am J Hum Genet; 2003 Oct; 73(4):835-48. PubMed ID: 12970845
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Premutation allele pool in myotonic dystrophy type 2.
    Bachinski LL; Czernuszewicz T; Ramagli LS; Suominen T; Shriver MD; Udd B; Siciliano MJ; Krahe R
    Neurology; 2009 Feb; 72(6):490-7. PubMed ID: 19020295
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Myotonic dystrophy type 2 in Japan: ancestral origin distinct from Caucasian families.
    Saito T; Amakusa Y; Kimura T; Yahara O; Aizawa H; Ikeda Y; Day JW; Ranum LP; Ohno K; Matsuura T
    Neurogenetics; 2008 Feb; 9(1):61-3. PubMed ID: 18057971
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Uninterrupted CCTG tracts in the myotonic dystrophy type 2 associated locus.
    Radvanszky J; Surovy M; Polak E; Kadasi L
    Neuromuscul Disord; 2013 Jul; 23(7):591-8. PubMed ID: 23561036
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Dutch myotonic dystrophy type 2 patients and a North-African DM2 family carry the common European founder haplotype.
    Coenen MJ; Tieleman AA; Schijvenaars MM; Leferink M; Ranum LP; Scheffer H; van Engelen BG
    Eur J Hum Genet; 2011 May; 19(5):567-70. PubMed ID: 21224892
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Repeat-primed polymerase chain reaction in myotonic dystrophy type 2 testing.
    Radvansky J; Ficek A; Kadasi L
    Genet Test Mol Biomarkers; 2011 Mar; 15(3):133-6. PubMed ID: 21204698
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Myotonic dystrophy type 2 caused by a CCTG expansion in intron 1 of ZNF9.
    Liquori CL; Ricker K; Moseley ML; Jacobsen JF; Kress W; Naylor SL; Day JW; Ranum LP
    Science; 2001 Aug; 293(5531):864-7. PubMed ID: 11486088
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Distribution and Structure of DM2 Repeat Tract Alleles in the German Population.
    Mahyera AS; Schneider T; Halliger-Keller B; Schrooten K; Hörner EM; Rost S; Kress W
    Front Neurol; 2018; 9():463. PubMed ID: 29973908
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Ancestral Origin of the First Indian Families with Myotonic Dystrophy Type 2.
    Damen M; Schijvenaars M; Schimmel-Naber M; Groothuismink J; Coenen M; Tieleman A
    J Neuromuscul Dis; 2021; 8(4):715-722. PubMed ID: 34024776
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effect of the [CCTG]n repeat expansion on ZNF9 expression in myotonic dystrophy type II (DM2).
    Botta A; Caldarola S; Vallo L; Bonifazi E; Fruci D; Gullotta F; Massa R; Novelli G; Loreni F
    Biochim Biophys Acta; 2006 Mar; 1762(3):329-34. PubMed ID: 16376058
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Myotonic dystrophy: emerging mechanisms for DM1 and DM2.
    Cho DH; Tapscott SJ
    Biochim Biophys Acta; 2007 Feb; 1772(2):195-204. PubMed ID: 16876389
    [TBL] [Abstract][Full Text] [Related]  

  • 13. DM2 CCTG*CAGG repeats are crossover hotspots that are more prone to expansions than the DM1 CTG*CAG repeats in Escherichia coli.
    Dere R; Wells RD
    J Mol Biol; 2006 Jun; 360(1):21-36. PubMed ID: 16753177
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Convergent myotonic dystrophy (DM) haplotypes: potential inconsistencies in human disease gene localization.
    Whiting EJ; Tsilfidis C; Surh L; MacKenzie AE; Korneluk RG
    Eur J Hum Genet; 1995; 3(3):195-202. PubMed ID: 7583045
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Myotonic dystrophy type 2 and related myotonic disorders.
    Meola G; Moxley RT
    J Neurol; 2004 Oct; 251(10):1173-82. PubMed ID: 15503094
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Molecular pathways to myotonic dystrophy].
    Ishiura S
    Nihon Rinsho; 2005 Mar; 63(3):515-21. PubMed ID: 15773354
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The unstable CCTG repeat responsible for myotonic dystrophy type 2 originates from an AluSx element insertion into an early primate genome.
    Kurosaki T; Ueda S; Ishida T; Abe K; Ohno K; Matsuura T
    PLoS One; 2012; 7(6):e38379. PubMed ID: 22723857
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [A pedigree with myotonic dystrophy: non-CTG, non-CCTG repeat expansion].
    Zhao XP; Xie HJ; Zheng HM; Yu ZL; Cui Y; Ding SJ; Ren DM; Tang GM
    Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2004 Oct; 21(5):459-62. PubMed ID: 15476170
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Biomolecular identification of (CCTG)n mutation in myotonic dystrophy type 2 (DM2) by FISH on muscle biopsy.
    Cardani R; Mancinelli E; Sansone V; Rotondo G; Meola G
    Eur J Histochem; 2004; 48(4):437-42. PubMed ID: 15718211
    [TBL] [Abstract][Full Text] [Related]  

  • 20. High resolution genetic analysis suggests one ancestral predisposing haplotype for the origin of the myotonic dystrophy mutation.
    Neville CE; Mahadevan MS; Barceló JM; Korneluk RG
    Hum Mol Genet; 1994 Jan; 3(1):45-51. PubMed ID: 7909252
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.